Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
Understanding Mechanisms of Acquired Resistance to BIBW2992
- Status
- COMPLETED
- Phase
- NA
Effects of Tiotropium on Breathing Capacity and Exercise Limitation in Early Stages of Chronic Obstructive Pulmonary Disease
- Status
- COMPLETED
- Phase
- PHASE4
Assessment of the Safety and Efficacy of Pramipexole Extended Release in Patients With Parkinson's Disease in Routine Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
Post-Marketing Surveillance of Micombi Tablets Survey on the Long-term Use
- Status
- COMPLETED
- Phase
- N/A
Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry II
- Status
- COMPLETED
- Phase
- PHASE3
A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease
- Status
- COMPLETED
- Phase
- PHASE3
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease
- Status
- COMPLETED
- Phase
- PHASE3
Determining Optimal Free Dose Combination of Tiotropium Bromide and BI 1744 CL in Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry I
- Status
- COMPLETED
- Phase
- PHASE3
Assessment of Chronic Obstructive Pulmonary Disease (COPD) Therapy From the Physicians Perspective Using Tiotropium as an Example
- Status
- COMPLETED
- Phase
- N/A
Compare Safety and Efficacy of BIBF 1120 Versus Sunitinib.
- Status
- COMPLETED
- Phase
- PHASE2
Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination of BI6727 (Volasertib) and BIBF1120 in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease
- Status
- COMPLETED
- Phase
- PHASE3
LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Safety and Efficacy of 4 Doses of BI 1744 CL Delivered Via the Respimat in Patients With Asthma.
- Status
- COMPLETED
- Phase
- PHASE2
Linagliptin 2.5 mg Twice Daily Versus 5 mg Once Daily as add-on Therapy to Twice Daily Metformin in Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Randomized, Placebo Controlled, Crossover Study in an Environmental Challenge Chamber to Assess Safety & Efficacy of Three Oral Doses of BI 671800 Versus Fluticasone Propionate and Montelukast in Sensitive Seasonal Allergic Rhinitis Patients Out of Season
- Status
- COMPLETED
- Phase
- PHASE2